Literature DB >> 1995562

Beta-mannosidosis in twelve Salers calves.

B Abbitt1, M Z Jones, T R Kasari, R W Storts, J W Templeton, P S Holland, P E Castenson.   

Abstract

A diagnosis of beta-mannosidosis, a lysosomal storage disease caused by a deficiency of beta-mannosidase, was made in 12 purebred Salers calves. Affected neonatal calves were unable to rise and had intention tremors, hidebound skin, slightly domed calvaria, slight prognathism, and narrow palpebral fissures. Postmortem findings included variable dilatation of the lateral cerebral ventricles, marked pallor and paucity of white matter of the cerebrum and cerebellum, and mild to marked bilateral renomegaly. Microscopic lesions consisted of clear, intracytoplasmic vacuoles, which were especially prominent in neurons, thyroid follicular cells, proximal renal tubular epithelium, and reticuloendothelial cells. By ultrastructural examination, the intracytoplasmic vacuoles were identified as membrane-bound lysosomes distended by lucent material. The serum of affected calves was profoundly deficient in beta-mannosidase. Oligosaccharides, principally a trisaccharide with a terminal hexose in the beta-anomeric configuration, accumulated in tissues of affected calves. The percentage (37.2) of affected calves from groups of siblings, the approximately equal sex ratio, and the phenotypic normalcy of the parents of affected calves are compatible with an autosomal recessive mode of inheritance typical of other glycoproteinoses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1995562

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  13 in total

1.  Thyroid structure and function in bovine beta-mannosidosis.

Authors:  K L Lovell; M Z Jones; J Patterson; B Abbitt; P Castenson
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Beta-mannosidase maps to cattle chromosome 6.

Authors:  S M Schmutz; J S Moker; J R Leipprandt; K H Friderici
Journal:  Mamm Genome       Date:  1996-06       Impact factor: 2.957

3.  Oligosaccharides accumulated in the bovine beta-mannosidosis kidney.

Authors:  M Z Jones; E J Rathke; D A Gage; C E Costello; K Murakami; M Ohta; F Matsuura
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

4.  Animal model of human disease. Bovine beta-mannosidosis.

Authors:  M Z Jones; B Abbitt
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

5.  Possible beta-mannosidosis chimera. Altered expression of metabolic perturbations.

Authors:  M Z Jones; K T Cavanagh; R Kranich; C Traviss; Y Fujita; M Ohta; F Matsuura
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Estimation of genotype distributions and posterior genotype probabilities for beta-mannosidosis in Salers cattle.

Authors:  J F Taylor; B Abbitt; J P Walter; S K Davis; J T Jaques; R F Ochoa
Journal:  Genetics       Date:  1993-11       Impact factor: 4.562

7.  A Clinically Severe Variant of β-Mannosidosis, Presenting with Neonatal Onset Epilepsy with Subsequent Evolution of Hydrocephalus.

Authors:  A Broomfield; R Gunny; I Ali; A Vellodi; P Prabhakar
Journal:  JIMD Rep       Date:  2013-04-16

8.  In vivo inhibition of beta-glucosidase and beta-mannosidase activity in rats by 2-deoxy-2-fluoro-beta-glycosyl fluorides and recovery of activity in vivo and in vitro.

Authors:  J D McCarter; M J Adam; N G Hartman; S G Withers
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

9.  Distribution and Severity of Neuropathology in β-Mannosidase-Deficient Mice is Strain Dependent.

Authors:  Kathryn L Lovell; Mei Zhu; Meghan C Drummond; Robert C Switzer; Karen H Friderici
Journal:  JIMD Rep       Date:  2013-10-20

10.  A MANBA mutation resulting in residual beta-mannosidase activity associated with severe leukoencephalopathy: a possible pseudodeficiency variant.

Authors:  Frédérique Sabourdy; Pierre Labauge; Hilde Monica Frostad Riise Stensland; Michèle Nieto; Violeta Latorre Garcés; Dimitri Renard; Giovanni Castelnovo; Nicolas de Champfleur; Thierry Levade
Journal:  BMC Med Genet       Date:  2009-09-03       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.